Drugs / Alvesco Inhalant Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06589245 | Sep 2025 → Aug 2026 overdue | bronchopulmonary dysplasia | Venkatesh Sampath | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alvesco Inhalant Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06589245 ↗ |